S I D E B A R
Format
Items per page
Sort by

Download:

Choose Destination

Search results

Items: 1 to 100 of 750

VariationLocationGene(s)Condition(s)Clinical significance
(Last reviewed)
Review status
1.
RAD51CFanconi anemia, complementation group OPathogenic
(Jan 17, 2015)
criteria provided, single submitter
2.
GRCh37:
Chr17:17711738-217748468
AANAT, ACACA, ASIC2, ACLY, ACOX1, ACTG1, AP2B1, ALDH3A1, ALDH3A2, ALDOC, AOC2, BIRC5, APOH, ARL4D, ARHGDIA, ATP5MC1, ATP6V0A1, BLMH, BRCA1, FMNL1, CA4, CACNB1, CACNG1, CD7, CD79B, CDC6, CDC27, CDK3, CHAD, CLTC, CCR7, CNP, COL1A1, COX11, CPD, CRHR1, CRYBA1, CSF3, CSH1, CSH2, CSHL1, CSNK1D, SLC25A10, CYB561, ACE, DDX5, DHX8, DLX3, DLX4, DRG2, DUSP3, ERBB2, ERN1, ETV4, EVI2A, EVI2B, EVPL, EZH1, BPTF, FASN, FDXR, FOXJ1, FLII, FLOT2, GAST, FZD2, G6PC, GAA, GALK1, GCGR, KAT2A, GFAP, GH1, GH2, GIP, GNGT2, CCR10, UTS2R, GPS1, GRB2, GRB7, GRN, GRIN2C, H3F3B, HCRT, HLF, HOXB1, HOXB2, HOXB3, HOXB4, HOXB5, HOXB6, HOXB7, HOXB8, HOXB9, HSD17B1, ICAM2, MRPL58, IFI35, IGFBP4, FOXK2, ITGA2B, ITGA3, ITGB3, ITGB4, JUP, KCNJ2, KCNJ12, KCNJ16, KPNB1, KPNA2, KRT9, KRT10, KRT12, KRT13, KRT14, KRT15, KRT16, KRT17, KRT19, KRT31, KRT32, KRT33A, KRT33B, KRT34, KRT35, LASP1, LGALS3BP, LGALS9, LHX1, LIG3, LLGL2, LLGL1, LPO, NBR1, MAFG, MAPT, ADAM11, MAP3K3, MEOX1, MFAP4, MLLT6, MPO, MPP2, MPP3, TRIM37, MYL4, MYO1D, NAGLU, NEUROD2, NF1, NFE2L1, NGFR, NME1, NME2, NMT1, NOS2, NPTX1, NSF, OMG, P4HB, PDE6G, PDK2, PECAM1, PEX12, PHB, PNMT, SEPT4, MED1, PPY, PRKAR1A, PRKCA, MAPK7, MAP2K3, MAP2K6, PRPSAP1, PRPSAP2, PSMB3, PYY, PSMC5, PSMD3, PSMD11, PSMD12, PYCR1, PCYT2, RAB5C, RAC3, RAD51C, RAD51D, RARA, RFNG, RPL19, RPL23A, RPL27, RPL38, MRPL12, RPS6KB1, SCN4A, CCL1, CCL2, CCL3, CCL3L1, CCL4, CCL5, CCL7, CCL8, CCL11, CCL13, CCL14, CCL15, CCL16, CCL18, CCL23, SDF2, SEC14L1, SECTM1, SRSF1, SRSF2, SGCA, SGSH, SHMT1, SLC4A1, SLC6A4, SMARCD2, SMARCE1, SUMO2, SOX9, SP2, SREBF1, SRP68, SSTR2, STAT3, STAT5A, STAT5B, SUPT4H1, SUPT6H, TADA2A, TBCD, TBX2, HNF1B, MLX, THRA, TIMP2, TK1, TNFAIP1, TOP2A, TOP3A, TRQ-TTG1-1, DNAJC7, TUBG1, UBTF, VTN, WNT3, WNT9B, PCGF2, TRIM25, VEZF1, RNF112, ZNF207, TAF15, RND2, COIL, AKAP1, EPX, AXIN2, PIP4K2B, SPOP, FOXN1, PPM1D, CNTNAP1, DGKE, CBX4, TCAP, SKAP1, DNAH17, AOC3, BECN1, KRT38, KRT37, KRT36, ABCC3, RGS9, GALR2, TMEM11, KSR1, CDK5R1, SPHK1, CACNA1G, HAP1, MAP3K14, SOCS3, SPAG9, SLC13A2, UNC119, MTMR4, SLC16A6, SLC16A5, SLC16A3, SYNGR2, HGS, TIAF1, NOG, TSPOAP1, CYTH1, ZNHIT3, EFTUD2, RPL23, SLC9A3R1, COG1, RECQL5, PGS1, TBX4, NPEPPS, GOSR1, CCL4L2, GOSR2, NR1D1, TRAF4, AATK, KIAA0100, ULK2, TBKBP1, TMEM94, EIF4A3, PLEKHM1, MED24, LRRC37A, MRC2, HELZ, MED13, HDAC5, TOM1L1, GJC1, TOB1, ALYREF, PSME3, EIF1, NBR2, SLC35B1, DCAF7, CALCOCO2, RAMP2, ABCA10, ABCA9, ABCA8, BAIAP2, ATP5PD, HOXB13, VAT1, APPBP2, FBXW10, P3H4, ST6GALNAC2, HEXIM1, SPAG5, IGF2BP1, GNA13, CCT6B, RAI1, GRAP, SEPT9, CD300C, C1QL1, RUNDC3A, STARD3, CBX1, RAB40B, TLK2, DDX52, DUSP14, KAT7, AKAP10, POLG2, NXPH3, SNF8, SYNRG, CD300A, TMC6, DDX42, CASC3, IKZF3, ZNF652, PPM1E, ARSG, EPN2, CEP131, SARM1, GPATCH8, GGA3, JMJD6, EXOC7, USP22, KCNH4, ABCA6, ABCA5, KCTD2, SUZ12, MMD, WBP2, CDC42EP4, FSCN2, NOL11, DHRS7B, KRT23, TMEM98, POLDIP2, TBC1D29P, TANC2, WSB1, NAT9, PITPNC1, ERAL1, NARF, AATF, OR4D1, B9D1, CACNG5, CACNG4, TUBG2, TMEM97, NKIRAS2, COA3, GIT1, SAP30BP, PSMC3IP, SNX11, TBX21, NT5C, SOCS7, CDR2L, SOST, TVP23B, MRPS7, UTP18, RNFT1, JPT1, MYO15A, TUBD1, DCXR, RAPGEFL1, TACO1, ABI3, COPZ2, MRPL27, PIPOX, AMZ2, ARL17A, CRLF3, ANAPC11, SIRT7, SLC25A39, MRPS23, PTRH2, NLK, LUC7L3, HIGD1B, CDK12, KRT20, NLE1, SDK2, FNDC8, FAM20A, MBTD1, BCAS3, TMEM104, CWC25, ALKBH5, RNF43, MKS1, C17orf80, CCDC40, EPN3, WIPI1, SLFN12, PNPO, KLHL11, SMG8, SLC47A1, TMEM100, RHOT1, RSAD1, COPRS, LRRC59, NPLOC4, FAM222B, PRR11, ADAP2, ST6GALNAC1, UTP6, TEX2, GSDMB, GPRC5C, TEX14, WDR45B, CA10, ATXN7L3, CCDC47, PLXDC1, LYZL6, CBX8, MIF4GD, INTS2, CASKIN2, RPTOR, NUFIP2, TAOK1, BAHCC1, USP36, ARHGAP23, PHF12, RNF213, TNRC6C, PCTP, SCPEP1, SLC25A19, FKBP10, UBE2O, HEATR6, DUS1L, FN3K, XYLT2, C17orf75, DNAI2, SMURF2, ENGASE, SPATA20, MRPL38, UBE2Z, WNK4, C17orf53, GID4, ASPSCR1, TMUB2, CARD14, DHX58, MMP28, DHRS11, MFSD11, PRR15L, CYBC1, ARMC7, CHMP6, RHBDF2, DHX40, FN3KRP, OGFOD3, TEFM, ZNF750, ACBD4, DCAKD, GGNBP2, NUP85, ATAD5, MRM1, PLEKHH3, DBF4B, MYO19, ACSF2, FAAP100, CDK5RAP3, SP6, COASY, SRCIN1, AARSD1, LIMD2, KCNH6, FAM117A, VMP1, KRTAP1-3, KRTAP1-1, KRTAP9-9, KRTAP4-6, KRTAP2-1, DRC3, TTC25, KRTAP4-12, RAB34, TSPAN10, KRTAP1-5, KRTAP3-1, KRTAP3-2, KRTAP9-2, KRTAP9-3, KRTAP9-8, KRTAP17-1, BRIP1, MYCBPAP, QRICH2, NSRP1, PPP1R1B, TBC1D3F, RNF135, MIEN1, MRPL45, VPS25, TMEM101, PRAC1, RAB11FIP4, GHDC, KRTAP4-4, KIF2B, USP32, PPP1R9B, CBX2, FAM104A, CORO6, TNS4, FBXL20, KRTAP9-4, KRTAP4-1, KRTAP4-5, KRTAP4-3, KRTAP4-2, KRTAP3-3, KRTAP2-4, FBF1, UNK, SSH2, TP53I13, IFT20, LRRC46, SCRN2, CEP95, TRIM47, ANKRD40, ZNF830, SLFN11, RASL10B, ATPAF2, STRADA, PRR29, SPECC1, G6PC3, ASB16, OTOP2, PGAP3, PIGS, TTYH2, HSPB9, ORMDL3, PLCD3, SLC46A1, TMEM106A, LRRC37B, CYGB, RNF157, OSBPL7, C1QTNF1, NT5C3B, ABHD15, TLCD1, PPP1R27, FTSJ3, RFFL, METTL23, HSF5, OR4D2, MSI2, SLC38A10, CANT1, USH1G, CD300LB, KIF19, ZPBP2, C17orf64, SPATA32, HEXIM2, LSM12, CCDC43, CNTD1, TMEM132E, WFIKKN2, B4GALNT2, SPACA3, SEZ6, ANKRD13B, EFCAB13, MRPL10, TBC1D16, AFMID, GJD3, KRT222, KRT40, MIEF2, SLC5A10, DYNLL2, SMCR8, MGAT5B, TOM1L2, TEPSIN, B3GNTL1, RBFOX3, CD300LF, C17orf77, EFCAB3, SLC47A2, C17orf50, SLFN13, SLC35G3, UNC45B, CD300LG, KIF18B, RUNDC1, EME1, TMEM199, PROCA1, DHRS13, NOTUM, TMC8, TRIM16L, WIPF2, KRT25, TMEM99, ANKFN1, MARCH10, SLFN5, NAGS, RETREG3, TMEM92, PHOSPHO1, RHBDL3, SPPL2C, KRT28, KRT24, CEP112, ARHGAP27, ZNF385C, SAMD14, LYRM9, CENPX, LRRC45, SLC39A11, TRIM65, UNC13D, RDM1, GAS2L2, STH, STXBP4, TBC1D28, TAC4, MYADML2, CDRT15L2, NATD1, NPB, HEATR9, FADS6, HID1, TSEN54, UBALD2, TMEM235, CCDC57, HEXD, C17orf58, MILR1, KANSL1, CFAP97D1, FAM171A2, MEIOC, TTLL6, C17orf47, NEK8, PIGW, C17orf78, CISD3, GSDMA, CAVIN1, SLC26A11, ENDOV, GDPD1, NDUFAF8, TMEM105, LGALS9B, METRNL, KLHL10, RAB37, METTL2A, CCDC144NL, C17orf67, ENPP7, OXLD1, CCDC137, ARL16, C17orf51, MSL1, CD300E, NACA2, KRT27, SLFN14, STAC2, OTOP3, SKA2, MCRIP1, GPR142, ZACN, KRT26, PRAC2, EFCAB5, LRRC37A3, TMIGD1, CCL4L1, C17orf98, CCDC103, RPRML, YPEL2, C17orf82, BTBD17, ARL5C, KRT39, MYO18A, GRAPL, C17orf102, TEX19, CUEDC1, MIR10A, MIR144, MIR152, MIR193A, MIR196A1, MIR21, TBC1D3B, TBC1D3C, CCL3L3, MXRA7, GPR179, MIR338, LRRC37A2, FBXO47, MIR451A, CPSF4L, SMIM5, FAM83G, EVPLL, SEBOX, KRTAP4-11, LGALS9C, NME1-NME2, MIR33B, KRTAP4-8, KRTAP1-4, KRTAP2-2, KRTAP9-1, ZNF286B, TBC1D3, TBC1D3H, KRTAP2-3, PRCD, SNORD3A, SMIM6, CD300LD, KRTAP4-9, KRTAP4-7, TEN1, C17orf99, EPOP, MTRNR2L1, LRRC3C, KRTAP9-7, KRTAP16-1, HEXD-IT1, ARL17B, C17orf112, SLFN12L, KRTAP9-6, PTGES3L, PTGES3L-AARSD1, LOC101927666
Smith-Magenis syndromePathogenic
(Nov 12, 2015)
criteria provided, single submitter
3.
GRCh37:
Chr17:56738493-56802671
RAD51C, TEX14Breast-ovarian cancer, familial 3Likely pathogenic
(May 1, 2017)
no assertion criteria provided
4.
GRCh37:
Chr17:56780657-56780755
RAD51CFanconi anemia, complementation group O, Hereditary cancer-predisposing syndromeUncertain significance
(Jul 9, 2017)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr17:56769956
GRCh38:
Chr17:58692595
RAD51Cnot specifiedLikely benign
(Nov 30, 2017)
criteria provided, single submitter
6.
GRCh37:
Chr17:56769957
GRCh38:
Chr17:58692596
RAD51Cnot specifiedBenign
(Sep 14, 2015)
criteria provided, single submitter
7.
GRCh37:
Chr17:56769964
GRCh38:
Chr17:58692603
RAD51Cnot specifiedLikely benign
(Mar 30, 2017)
criteria provided, single submitter
8.
GRCh37:
Chr17:56769966
GRCh38:
Chr17:58692605
RAD51Cnot specifiedLikely benign
(Dec 11, 2017)
criteria provided, single submitter
9.
GRCh37:
Chr17:56769969
GRCh38:
Chr17:58692608
RAD51Cnot specifiedLikely benign
(Mar 4, 2016)
criteria provided, single submitter
10.
GRCh37:
Chr17:56769970
GRCh38:
Chr17:58692609
RAD51Cnot specifiedLikely benign
(Sep 19, 2016)
criteria provided, single submitter
11.
GRCh37:
Chr17:56769976
GRCh38:
Chr17:58692615
RAD51Cnot specifiedLikely benign
(Sep 19, 2016)
criteria provided, single submitter
12.
GRCh37:
Chr17:56769977
GRCh38:
Chr17:58692616
RAD51Cnot specifiedLikely benign
(Apr 1, 2016)
criteria provided, single submitter
13.
GRCh37:
Chr17:56769979
GRCh38:
Chr17:58692618
RAD51CFanconi anemia, Breast and Ovarian Cancer SusceptibilityLikely benign
(Jun 14, 2016)
criteria provided, single submitter
14.
GRCh37:
Chr17:56769981
GRCh38:
Chr17:58692620
RAD51Cnot specifiedLikely benign
(Jul 28, 2017)
criteria provided, single submitter
15.
GRCh37:
Chr17:56769981
GRCh38:
Chr17:58692620
RAD51Cnot specifiedLikely benign
(Jun 15, 2016)
criteria provided, single submitter
16.
GRCh37:
Chr17:56769981
GRCh38:
Chr17:58692620
RAD51Cnot specifiedLikely benign
(Dec 18, 2017)
criteria provided, single submitter
17.
GRCh37:
Chr17:56769983
GRCh38:
Chr17:58692622
RAD51Cnot specifiedLikely benign
(Jul 25, 2016)
criteria provided, single submitter
18.
GRCh37:
Chr17:56769985
GRCh38:
Chr17:58692624
RAD51CHereditary cancer-predisposing syndromeLikely benign
(Aug 11, 2015)
criteria provided, single submitter
19.
GRCh37:
Chr17:56769986
GRCh38:
Chr17:58692625
RAD51Cnot specified, Hereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Nov 30, 2017)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr17:56769986
GRCh38:
Chr17:58692625
RAD51Cnot specifiedLikely benign
(Jan 5, 2016)
criteria provided, single submitter
21.
GRCh37:
Chr17:56769987
GRCh38:
Chr17:58692626
RAD51CHereditary cancer-predisposing syndromeLikely benign
(Jul 6, 2017)
criteria provided, single submitter
22.
GRCh37:
Chr17:56769990
GRCh38:
Chr17:58692629
RAD51CHereditary cancer-predisposing syndromeLikely benign
(Mar 17, 2017)
criteria provided, single submitter
23.
GRCh37:
Chr17:56769992
GRCh38:
Chr17:58692631
RAD51Cnot provided, Hereditary cancer-predisposing syndromeLikely benign
(Jul 7, 2017)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr17:56769997
GRCh38:
Chr17:58692636
RAD51Cnot specified, not provided, Hereditary cancer-predisposing syndrome
Likely benign
(Jan 4, 2018)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr17:56769998
GRCh38:
Chr17:58692637
RAD51Cnot specifiedLikely benign
(Dec 9, 2015)
criteria provided, single submitter
26.
GRCh37:
Chr17:56769999
GRCh38:
Chr17:58692638
RAD51CHereditary cancer-predisposing syndromeLikely benign
(Apr 26, 2017)
criteria provided, single submitter
27.
GRCh37:
Chr17:56770000
GRCh38:
Chr17:58692639
RAD51Cnot specified, Hereditary cancer-predisposing syndromeUncertain significance
(Dec 29, 2016)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr17:56770001
GRCh38:
Chr17:58692640
RAD51Cnot specified, Hereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Sep 22, 2017)
criteria provided, conflicting interpretations
29.
GRCh37:
Chr17:56770002
GRCh38:
Chr17:58692641
RAD51CFanconi anemia, complementation group OUncertain significance
(Jul 18, 2015)
criteria provided, single submitter
30.
GRCh37:
Chr17:56770003
GRCh38:
Chr17:58692642
RAD51CHereditary cancer-predisposing syndromeUncertain significance
(Mar 15, 2015)
criteria provided, single submitter
31.
GRCh37:
Chr17:56770004
GRCh38:
Chr17:58692643
RAD51CHereditary cancer-predisposing syndromeUncertain significance
(Oct 3, 2017)
criteria provided, single submitter
32.
GRCh37:
Chr17:56770007
GRCh38:
Chr17:58692646
RAD51CFanconi anemia, complementation group O, Hereditary breast and ovarian cancer syndrome, not specified,
Hereditary cancer-predisposing syndrome
Uncertain significance
(Jul 2, 2018)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr17:56770007
GRCh38:
Chr17:58692646
RAD51CFanconi anemia, complementation group O, not specified, not provided,
Hereditary cancer-predisposing syndrome
Uncertain significance
(May 6, 2018)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr17:56770008
GRCh38:
Chr17:58692647
RAD51CBreast-ovarian cancer, familial 3, Fanconi anemia, complementation group OUncertain significance
(Mar 30, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr17:56770011
GRCh38:
Chr17:58692650
RAD51CFanconi anemia, complementation group O, not provided, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(May 15, 2018)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr17:56770012
GRCh38:
Chr17:58692651
RAD51CFanconi anemia, complementation group OUncertain significance
(Jan 13, 2017)
criteria provided, single submitter
37.
GRCh37:
Chr17:56770013
GRCh38:
Chr17:58692652
RAD51CFanconi anemia, complementation group O, not specified, Hereditary cancer-predisposing syndrome
Likely benign
(Sep 12, 2017)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr17:56770016
GRCh38:
Chr17:58692655
RAD51CFamilial cancer of breast, Hereditary cancer-predisposing syndromeLikely benign
(May 2, 2016)
criteria provided, single submitter
39.
GRCh37:
Chr17:56770018
GRCh38:
Chr17:58692657
RAD51CHereditary cancer-predisposing syndromeUncertain significance
(May 30, 2017)
criteria provided, single submitter
40.
GRCh37:
Chr17:56770018
GRCh38:
Chr17:58692657
RAD51CBreast-ovarian cancer, familial 3, Fanconi anemia, complementation group O, not provided,
Hereditary cancer-predisposing syndrome
Uncertain significance
(May 29, 2018)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr17:56770021
GRCh38:
Chr17:58692660
RAD51CFanconi anemia, complementation group O, not specified, Hereditary cancer-predisposing syndrome
Uncertain significance
(May 18, 2018)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr17:56770022
GRCh38:
Chr17:58692661
RAD51CFanconi anemia, complementation group OUncertain significance
(Jan 24, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr17:56770023
GRCh38:
Chr17:58692662
RAD51CFanconi anemia, complementation group OUncertain significance
(Mar 27, 2018)
criteria provided, single submitter
44.
GRCh37:
Chr17:56770023
GRCh38:
Chr17:58692662
RAD51CFanconi anemia, complementation group OUncertain significance
(Apr 13, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr17:56770023
GRCh38:
Chr17:58692662
RAD51CFanconi anemia, complementation group O, Hereditary cancer-predisposing syndromeUncertain significance
(Feb 19, 2018)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr17:56770024
GRCh38:
Chr17:58692663
RAD51CFanconi anemia, complementation group O, Hereditary cancer-predisposing syndromeUncertain significance
(Mar 30, 2018)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr17:56770028
GRCh38:
Chr17:58692667
RAD51Cnot provided, Hereditary cancer-predisposing syndromeUncertain significance
(Feb 23, 2017)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr17:56770032
GRCh38:
Chr17:58692671
RAD51CFanconi anemia, complementation group O, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(May 20, 2018)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr17:56770033
GRCh38:
Chr17:58692672
RAD51CFanconi anemia, complementation group O, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(May 21, 2018)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr17:56770034
GRCh38:
Chr17:58692673
RAD51CFanconi anemia, complementation group OUncertain significance
(Oct 13, 2017)
criteria provided, single submitter
51.
GRCh37:
Chr17:56770035
GRCh38:
Chr17:58692674
RAD51CFanconi anemia, complementation group OPathogenic
(Feb 23, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr17:56770036
GRCh38:
Chr17:58692675
RAD51CFanconi anemia, complementation group O, Hereditary breast and ovarian cancer syndrome, not specified,
not provided
Uncertain significance
(Jul 2, 2018)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr17:56770038
GRCh38:
Chr17:58692677
RAD51CFanconi anemia, complementation group O, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(Mar 23, 2018)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr17:56770040
GRCh38:
Chr17:58692679
RAD51CHereditary cancer-predisposing syndromeLikely benign
(Mar 30, 2016)
criteria provided, single submitter
55.
GRCh37:
Chr17:56770040
GRCh38:
Chr17:58692679
RAD51CHereditary cancer-predisposing syndromeLikely benign
(Mar 12, 2015)
criteria provided, single submitter
56.
GRCh37:
Chr17:56770041
GRCh38:
Chr17:58692680
RAD51CFanconi anemia, complementation group OUncertain significance
(Apr 13, 2018)
criteria provided, single submitter
57.
GRCh37:
Chr17:56770041
GRCh38:
Chr17:58692680
RAD51CFanconi anemia, complementation group OUncertain significance
(Mar 30, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr17:56770048
GRCh38:
Chr17:58692687
RAD51CFanconi anemia, complementation group OUncertain significance
(Mar 20, 2018)
criteria provided, single submitter
59.
GRCh37:
Chr17:56770051
GRCh38:
Chr17:58692690
RAD51CFanconi anemia, complementation group OUncertain significance
(Dec 29, 2017)
criteria provided, single submitter
60.
GRCh37:
Chr17:56770054
GRCh38:
Chr17:58692693
RAD51CFanconi anemia, complementation group OPathogenic
(Dec 28, 2017)
criteria provided, single submitter
61.
GRCh37:
Chr17:56770056
GRCh38:
Chr17:58692695
RAD51Cnot provided, Hereditary cancer-predisposing syndromeUncertain significance
(Feb 5, 2018)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr17:56770057
GRCh38:
Chr17:58692696
RAD51CFanconi anemia, complementation group O, Hereditary cancer-predisposing syndromeUncertain significance
(Jan 10, 2018)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr17:56770058
GRCh38:
Chr17:58692697
RAD51CFanconi anemia, complementation group OLikely benign
(Dec 27, 2017)
criteria provided, single submitter
64.
GRCh37:
Chr17:56770059
GRCh38:
Chr17:58692698
RAD51Cnot specifiedLikely benign
(Jan 4, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr17:56770059
GRCh38:
Chr17:58692698
RAD51Cnot specifiedUncertain significance
(Jan 2, 2017)
criteria provided, single submitter
66.
GRCh37:
Chr17:56770063
GRCh38:
Chr17:58692702
RAD51CFanconi anemia, complementation group OUncertain significance
(Nov 9, 2017)
criteria provided, single submitter
67.
GRCh37:
Chr17:56770063
GRCh38:
Chr17:58692702
RAD51CFanconi anemia, complementation group O, Hereditary cancer-predisposing syndromeUncertain significance
(Mar 30, 2018)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr17:56770065
GRCh38:
Chr17:58692704
RAD51CFanconi anemia, complementation group O, Hereditary cancer-predisposing syndromeUncertain significance
(Apr 24, 2018)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr17:56770065
GRCh38:
Chr17:58692704
RAD51CFanconi anemia, complementation group O, Hereditary cancer-predisposing syndromeUncertain significance
(Jun 9, 2015)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr17:56770066
GRCh38:
Chr17:58692705
RAD51CFanconi anemia, complementation group O, Hereditary cancer-predisposing syndromeUncertain significance
(May 1, 2018)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr17:56770070
GRCh38:
Chr17:58692709
RAD51CHereditary cancer-predisposing syndromeLikely benign
(Nov 12, 2017)
criteria provided, single submitter
72.
GRCh37:
Chr17:56770070
GRCh38:
Chr17:58692709
RAD51Cnot specified, Hereditary cancer-predisposing syndromeLikely benign
(Apr 20, 2017)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr17:56770070
GRCh38:
Chr17:58692709
RAD51CFanconi anemia, complementation group O, not specified, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(May 14, 2018)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr17:56770073
GRCh38:
Chr17:58692712
RAD51CHereditary cancer-predisposing syndromeLikely benign
(Jun 2, 2015)
criteria provided, single submitter
75.
GRCh37:
Chr17:56770074
GRCh38:
Chr17:58692713
RAD51CFanconi anemia, complementation group OUncertain significance
(Nov 13, 2015)
criteria provided, single submitter
76.
GRCh37:
Chr17:56770075
GRCh38:
Chr17:58692714
RAD51Cnot specifiedUncertain significance
(Aug 11, 2016)
criteria provided, single submitter
77.
GRCh37:
Chr17:56770075
GRCh38:
Chr17:58692714
RAD51CFanconi anemia, complementation group O, not specified, not provided,
Hereditary cancer-predisposing syndrome
Uncertain significance
(Jun 29, 2018)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr17:56770077
GRCh38:
Chr17:58692716
RAD51CFanconi anemia, complementation group OPathogenic
(May 29, 2018)
criteria provided, single submitter
79.
GRCh37:
Chr17:56770077
GRCh38:
Chr17:58692716
RAD51Cnot provided, Hereditary cancer-predisposing syndromeUncertain significance
(Jul 14, 2017)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr17:56770079
GRCh38:
Chr17:58692718
RAD51CHereditary cancer-predisposing syndromeLikely benign
(May 5, 2015)
criteria provided, single submitter
81.
GRCh37:
Chr17:56770081
GRCh38:
Chr17:58692720
RAD51CBreast-ovarian cancer, familial 3, Fanconi anemia, complementation group O, Hereditary cancer-predisposing syndrome
Uncertain significance
(Sep 13, 2017)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr17:56770082
GRCh38:
Chr17:58692721
RAD51CFanconi anemia, complementation group OLikely benign
(Sep 19, 2015)
criteria provided, single submitter
83.
GRCh37:
Chr17:56770083
GRCh38:
Chr17:58692722
RAD51Cnot specified, Hereditary cancer-predisposing syndromeLikely benign
(Jun 12, 2017)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr17:56770084
GRCh38:
Chr17:58692723
RAD51CFanconi anemia, complementation group O, Hereditary cancer-predisposing syndromeUncertain significance
(May 2, 2018)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr17:56770086
GRCh38:
Chr17:58692725
RAD51CHereditary cancer-predisposing syndromeUncertain significance
(May 9, 2016)
criteria provided, single submitter
86.
GRCh37:
Chr17:56770086
GRCh38:
Chr17:58692725
RAD51CFanconi anemia, complementation group OUncertain significance
(Jun 20, 2016)
criteria provided, single submitter
87.
GRCh37:
Chr17:56770088
GRCh38:
Chr17:58692727
RAD51CHereditary cancer-predisposing syndromeLikely benign
(Sep 8, 2016)
criteria provided, single submitter
88.
GRCh37:
Chr17:56770090
GRCh38:
Chr17:58692729
RAD51CFanconi anemia, complementation group O, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(Mar 27, 2018)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr17:56770091
GRCh38:
Chr17:58692730
RAD51CFanconi anemia, Fanconi anemia, complementation group O, not specified,
Hereditary cancer-predisposing syndrome, Breast and Ovarian Cancer Susceptibility
Conflicting interpretations of pathogenicity
(Nov 8, 2017)
criteria provided, conflicting interpretations
90.
GRCh37:
Chr17:56770092
GRCh38:
Chr17:58692731
RAD51CFanconi anemia, complementation group O, Hereditary cancer-predisposing syndromeUncertain significance
(Feb 19, 2018)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr17:56770093
GRCh38:
Chr17:58692732
RAD51CFanconi anemia, complementation group O, Hereditary cancer-predisposing syndromeUncertain significance
(Jun 8, 2018)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr17:56770094
GRCh38:
Chr17:58692733
RAD51CFanconi anemia, Breast-ovarian cancer, familial 3, Fanconi anemia, complementation group O,
not specified, Hereditary cancer-predisposing syndrome, Breast and Ovarian Cancer Susceptibility
Benign/Likely benign
(Jan 25, 2018)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr17:56770096
GRCh38:
Chr17:58692735
RAD51CHereditary cancer-predisposing syndromeUncertain significance
(Aug 1, 2014)
criteria provided, single submitter
94.
GRCh37:
Chr17:56770097
GRCh38:
Chr17:58692736
RAD51Cnot specifiedLikely benign
(Sep 9, 2016)
criteria provided, single submitter
95.
GRCh37:
Chr17:56770097
GRCh38:
Chr17:58692736
RAD51CBreast-ovarian cancer, familial 3, Fanconi anemia, complementation group O, Hereditary breast and ovarian cancer syndrome,
not provided, Hereditary cancer-predisposing syndrome
Pathogenic
(Apr 2, 2018)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr17:56770101
GRCh38:
Chr17:58692740
RAD51CBreast-ovarian cancer, familial 3, Fanconi anemia, complementation group O, Hereditary breast and ovarian cancer syndrome,
not provided, Hereditary cancer-predisposing syndrome
Pathogenic
(Jun 21, 2018)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr17:56770101-56770102
GRCh38:
Chr17:58692740-58692741
RAD51CFanconi anemia, complementation group OPathogenic
(Jan 25, 2017)
criteria provided, single submitter
98.
GRCh37:
Chr17:56770106
GRCh38:
Chr17:58692745
RAD51Cnot specified, Hereditary cancer-predisposing syndromeLikely benign
(Aug 26, 2017)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr17:56770108
GRCh38:
Chr17:58692747
RAD51CFanconi anemia, complementation group OUncertain significance
(Jun 22, 2017)
criteria provided, single submitter
100.
GRCh37:
Chr17:56770110
GRCh38:
Chr17:58692749
RAD51CFanconi anemia, complementation group O, not specified, Hereditary cancer-predisposing syndrome
Uncertain significance
(Jun 24, 2018)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by

Download:

Choose Destination
Support Center